Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.

Pisa D, Alonso R, Jiménez-Jiménez FJ, Carrasco L.

Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):795-801. doi: 10.1007/s10096-012-1810-8. Epub 2013 Jan 16.

PMID:
23322279
2.

Fungal infection in a patient with multiple sclerosis.

Pisa D, Alonso R, Carrasco L.

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1173-80. doi: 10.1007/s10096-011-1206-1. Epub 2011 May 1.

PMID:
21533622
3.

Diagnosis of neuroparacoccidioidomycosis by detection of circulating antigen and antibody in cerebrospinal fluid.

da Silva SH, Colombo AL, Blotta MH, Queiroz-Telles F, Lopes JD, de Camargo ZP.

J Clin Microbiol. 2005 Sep;43(9):4680-3.

4.

Association between multiple sclerosis and Candida species: evidence from a case-control study.

Benito-León J, Pisa D, Alonso R, Calleja P, Díaz-Sánchez M, Carrasco L.

Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1139-45. doi: 10.1007/s10096-010-0979-y. Epub 2010 Jun 17.

PMID:
20556470
5.

Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis.

Alonso R, Pisa D, Marina AI, Morato E, Rábano A, Rodal I, Carrasco L.

Int J Biol Sci. 2015 Apr 2;11(5):546-58. doi: 10.7150/ijbs.11084. eCollection 2015.

6.

Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata.

Pisa D, Ramos M, Molina S, García P, Carrasco L.

J Med Microbiol. 2007 May;56(Pt 5):571-8.

7.

Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls.

Sotgiu S, Piana A, Pugliatti M, Sotgiu A, Deiana GA, Sgaramella E, Muresu E, Rosati G.

Mult Scler. 2001 Dec;7(6):371-4.

PMID:
11795458
8.

Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.

Filaci G, Contini P, Brenci S, Gazzola P, Lanza L, Scudeletti M, Indiveri F, Mancardi GL, Puppo F.

Hum Immunol. 1997 Apr 15;54(1):54-62.

PMID:
9154458
9.

Human spumaretrovirus antibody reactivity in multiple sclerosis.

Lycke J, Svennerholm B, Svenningsson A, Muranyi W, Flügel RM, Andersen O.

J Neurol. 1994 Feb;241(4):204-9.

PMID:
8195818
10.

Fungal infection in patients with serpiginous choroiditis or acute zonal occult outer retinopathy.

Pisa D, Ramos M, García P, Escoto R, Barraquer R, Molina S, Carrasco L.

J Clin Microbiol. 2008 Jan;46(1):130-5. Epub 2007 Nov 14.

11.

Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.

Mouzaki A, Rodi M, Dimisianos N, Emmanuil A, Kalavrizioti D, Lagoudaki R, Grigoriadis NC, Papathanasopoulos P.

PLoS One. 2015 Aug 28;10(8):e0135434. doi: 10.1371/journal.pone.0135434. eCollection 2015. Erratum in: PLoS One. 2016;11(3):e0151411.

12.

Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.

Fialová L, Bartos A, Svarcová J, Zimova D, Kotoucova J, Malbohan I.

J Neuroimmunol. 2013 Sep 15;262(1-2):113-20. doi: 10.1016/j.jneuroim.2013.06.010. Epub 2013 Jul 17.

PMID:
23870535
13.

Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients.

Ciusani E, Frigerio S, Gelati M, Corsini E, Dufour A, Nespolo A, La Mantia L, Milanese C, Massa G, Salmaggi A.

J Neuroimmunol. 1998 Feb;82(1):5-12.

PMID:
9526840
14.

IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.

Rentzos M, Cambouri C, Rombos A, Nikolaou C, Anagnostouli M, Tsoutsou A, Dimitrakopoulos A, Triantafyllou N, Vassilopoulos D.

J Neurol Sci. 2006 Feb 15;241(1-2):25-9. Epub 2005 Nov 28.

PMID:
16316662
15.

Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.

Stilund M, Gjelstrup MC, Petersen T, Møller HJ, Rasmussen PV, Christensen T.

PLoS One. 2015 Apr 10;10(4):e0119681. doi: 10.1371/journal.pone.0119681. eCollection 2015.

16.

Increased intrathecal high-avidity anti-tau antibodies in patients with multiple sclerosis.

Fialová L, Bartos A, Svarcová J, Malbohan I.

PLoS One. 2011;6(11):e27476. doi: 10.1371/journal.pone.0027476. Epub 2011 Nov 29.

17.

Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Parkhomenko TA, Doronin VB, Castellazzi M, Padroni M, Pastore M, Buneva VN, Granieri E, Nevinsky GA.

PLoS One. 2014 Apr 15;9(4):e93001. doi: 10.1371/journal.pone.0093001. eCollection 2014.

19.

Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.

Wu A, Zhong X, Wang H, Xu W, Cheng C, Dai Y, Bao J, Qiu W, Lu Z, Hu X.

Can J Neurol Sci. 2012 Nov;39(6):813-20.

PMID:
23041403
20.

T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis.

Söderström M, Link H, Sun JB, Fredrikson S, Kostulas V, Höjeberg B, Li BL, Olsson T.

Scand J Immunol. 1993 Mar;37(3):355-68.

PMID:
7680141

Supplemental Content

Support Center